BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32297703)

  • 1. Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open-label, controlled phase II clinical trial.
    Yang CC; Sung PH; Cheng BC; Li YC; Chen YL; Lee MS; Yip HK
    Stem Cells Transl Med; 2020 Aug; 9(8):827-838. PubMed ID: 32297703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial.
    Lee MS; Lee FY; Chen YL; Sung PH; Chiang HJ; Chen KH; Huang TH; Chen YL; Chiang JY; Yin TC; Chang HW; Yip HK
    Oncotarget; 2017 Mar; 8(11):17750-17762. PubMed ID: 28148896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
    Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.
    Schmidt-Lucke C; Fichtlscherer S; Aicher A; Tschöpe C; Schultheiss HP; Zeiher AM; Dimmeler S
    PLoS One; 2010 Nov; 5(11):e13790. PubMed ID: 21072182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells.
    Guerin CL; Guyonnet L; Goudot G; Revets D; Konstantinou M; Chipont A; Chocron R; Blandinieres A; Khider L; Rancic J; Peronino C; Debuc B; Cras A; Knosp C; Latremouille C; Capel A; Ollert M; Diehl JL; Jansen P; Planquette B; Sanchez O; Gaussem P; Mirault T; Carpentier A; Gendron N; Smadja DM
    Stem Cell Rev Rep; 2021 Apr; 17(2):639-651. PubMed ID: 33205351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study.
    Bonello L; Frere C; Cointe S; Laine M; Mancini J; Thuny F; Kerbaul F; Lemesle G; Paganelli F; Guieu R; Arnaud L; Dignat-George F; Sabatier F
    Int J Cardiol; 2015; 187():502-7. PubMed ID: 25846661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
    Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
    Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?
    António N; Soares A; Carvalheiro T; Fernandes R; Paiva A; Ventura M; Cristóvão J; Elvas L; Gonçalves L; Providência LA; Ribeiro CF; Pego GM
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):731-9. PubMed ID: 24383551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
    George J; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Tissue Eng; 2006 Feb; 12(2):331-5. PubMed ID: 16548691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.
    Lake JE; Seang S; Kelesidis T; Currier JS; Yang OO
    HIV Clin Trials; 2016 Nov; 17(6):225-232. PubMed ID: 27658740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary Transfusion of Circulation-Derived CD34+ Cells Improves Left Ventricular Function in Patients With End-Stage Diffuse Coronary Artery Disease Unsuitable for Coronary Intervention.
    Lee FY; Chen YL; Sung PH; Ma MC; Pei SN; Wu CJ; Yang CH; Fu M; Ko SF; Leu S; Yip HK
    Crit Care Med; 2015 Oct; 43(10):2117-32. PubMed ID: 26154930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of moderate-to-severe chronic kidney disease on flow-mediated dilation and progenitor cells.
    Kuczmarski JM; Darocki MD; DuPont JJ; Sikes RA; Cooper CR; Farquhar WB; Edwards DG
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1085-92. PubMed ID: 21791552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.
    Cappellari R; D'Anna M; Avogaro A; Fadini GP
    Atherosclerosis; 2016 Aug; 251():373-380. PubMed ID: 27255499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access.
    Wu CC; Huang PH; Lai CL; Leu HB; Chen JW; Lin SJ
    PLoS One; 2014; 9(6):e101058. PubMed ID: 24964143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.
    Esposito K; Ciotola M; Maiorino MI; Giugliano F; Autorino R; De Sio M; Jannini E; Lenzi A; Giugliano D
    J Sex Med; 2009 Jan; 6(1):107-14. PubMed ID: 19170841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients.
    Hsieh MY; Chen TY; Lin L; Chuang SY; Lin SJ; Tarng DC; Huang PH; Wu CC
    Nephrol Dial Transplant; 2017 Mar; 32(3):556-564. PubMed ID: 28339557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
    Sung PH; Chen KH; Li YC; Chiang JY; Lee MS; Yip HK
    Biomed Pharmacother; 2019 Mar; 111():1088-1102. PubMed ID: 30841422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients.
    Ye G; Chen X; Zhou Y; Zhou J; Song Y; Yang X; Yang L
    Mediators Inflamm; 2023; 2023():4450772. PubMed ID: 37899988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.